SUB-TYPE: CLASS 4 CAUTION IN USE
Aspen Pharma Trading Limited has informed the MHRA that an error has been found in the Patient Information Leaflet.
MHRA Drug alert date: 25th July 2024
Pip code | Product description | Supplier | Batch Numbers |
0257683 | CO-TRIMOX SUSP 80/400MG/5ML ASP | ASPEN PHARMACARE UK LTD | See above link |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please contact: Aspenmedinfo@professionalinformation.co.uk,
Tel: 0800 008 7392
SUB-TYPE: CLASS 4 CAUTION IN USE
Fresenius Kabi Limited has informed the MHRA of a labelling error on the packaging of Hartmann’s solution for Injection BP as Steriflex No.11 or freeflex.
MHRA Drug alert date: 24th July 2024
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | FREEFLEX/STERIFLEX NO 11 HARTMANN'S SOLUTION 500ML | FRESENIUS KABI | 14TB7322 14TD7312 14TE7326 |
This is a caution in use only we are not accepting stock returns
Further Information
For more information or medical information queries please email
Medical.Information-UK@fresenius-kabi.com or telephone +44 (0) 1928533575.
For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758.
SUB-TYPE: CLASS 2 RECALL
Glaxo Wellcome UK Ltd (GSK) has informed the MHRA that vials of Flolan 1.5 mg Powder and Solvent for Solution for Infusion, batch number AB8M may have been damaged during the packaging process.
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-glaxo-wellcome-uk-limited-trading-as-glaxosmithkline-uk-flolan-1-dot-5-mg-powder-and-solvent-for-solution-for-infusion-el-24-a-slash-30
Pip code | Product Description | Affected Batches |
4034997 | FLOLAN DIL INJ 1.5MG | AB8M |
Further Information
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
For more information on stock and resupply queries, contact your hospital or homecare provider. In the case of NHS trusts please contact 0800 221 441.
Should you have any questions or require additional information, please contact GSK Medical Information Department at ukmedinfo@gsk.com or alternatively contact 0800 221 441.
SUB-TYPE:
We are pleased to announce that, as of 01 August 2024, Alliance Healthcare UK will become the only wholesaler to supply selected products of Flynn Pharma’s product portfolio to all pharmacies, hospital pharmacies, and doctors in the United Kingdom, including Northern Ireland.
Click here for full product details.
SUB-TYPE: CLASS 2 RECALL
Sun Pharmaceutical Industries Europe B.V. is recalling the listed batches as a precautionary measure due to visible particulate matter during stability testing.
Pip code | Product Description | Affected Batches |
1264035 | PEMETREXED INF BAG 1000MG SUN | HAF0083A |
1263979 | PEMETREXED INF BAG 1100MG SUN | HAE0425A |
Further Information
For medical information enquiries please contact, medinfoeurope@sunpharma.com.
For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
Sun Pharma UK Ltd is recalling certain batches as a precautionary measure due to a small number of leaks found intermittently in the infusion bags.
Pip code | Product Description | Affected Batches |
1211135 | GEMCITABINE INF BAG 1800MG SUN | HAD3634A |
1211119 | GEMCITABINE INF BAG 1600MG SUN | HAE1532A |
1244367 | IRINOTECAN INF BAG 360MG SUN | HAE1191A |
Further Information
For medical information enquiries please contact, medinfoeurope@sunpharma.com.
For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Chelonia Healthcare Limited has informed the MHRA that an error relating to the product description was identified in the Patient Information Leaflet (PIL) for the batches listed in this notification.
MHRA Drug alert date: 9th July 2024
Pip code | Product description | Supplier | Batch Numbers |
8057119 | PROPANTHELINE BROMIDE TAB 15MG | GENESIS PHARMACEUTICALS LTD | SEE ATTACHED |
This is a caution in use only we are not accepting stock returns
Further Information
For stock control queries please contact info@genesis-pharma.com (Tel 020 7201 0400)
For Medical queries please contact eupvg@genreg.eu (Tel: 020 7201 0421).
SUB-TYPE: CLASS 2 RECALL
Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals.
Pip code | Product Description | Affected Batches |
8073249 | ITRACONAZOLE SF SOLN 10MG/ML | 231069 231071 |
Further Information
For medical information enquiries please contact medical@kent-athlone.com
For stock control enquiries please contact customer.services@kent-athlone.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 3 RECALL
Accord Healthcare Ltd is recalling various batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
Pip code | product description | batch number |
1204288 | ATOMOXETINE CAP 10MG ACC (28) | SEE ABOVE LINK |
1204270 | ATOMOXETINE CAP 10MG ACC (7) | SEE ABOVE LINK |
1204304 | ATOMOXETINE CAP 18MG ACC (28) | SEE ABOVE LINK |
1204296 | ATOMOXETINE CAP 18MG ACC (7) | SEE ABOVE LINK |
1204320 | ATOMOXETINE CAP 25MG ACC (28) | SEE ABOVE LINK |
1204312 | ATOMOXETINE CAP 25MG ACC (7) | SEE ABOVE LINK |
1204346 | ATOMOXETINE CAP 40MG ACC (28) | SEE ABOVE LINK |
1204338 | ATOMOXETINE CAP 40MG ACC (7) | SEE ABOVE LINK |
1204353 | ATOMOXETINE CAP 60MG ACC | SEE ABOVE LINK |
1204361 | ATOMOXETINE CAP 100MG ACC | SEE ABOVE LINK |
1204379 | ATOMOXETINE CAP 80MG ACC | SEE ABOVE LINK |
8009359 | ATOMOXETINE CAP 18MG | SEE ABOVE LINK |
8011314 | ATOMOXETINE CAP 60MG | SEE ABOVE LINK |
8011322 | ATOMOXETINE CAP 80MG | SEE ABOVE LINK |
Further Information
For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257
For stock control enquiries please contact Accord- UK Ltd Customer Services Team on 0800 373573.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CSR ACHIEVEMENTS
Teams from Alliance Healthcare and Alloga have successfully raised £10,000 for Action Medical Research following the Race the Sun Jurassic Coast Challenge 2024, involving over 30 dedicated team members from across the business.
Participants tackled a 27-mile cycle, a 2-mile canoe, and a 9.6-mile hike along the scenic Jurassic Coast. For the first time, team members also had the option to participate solely in the 9.6-mile hike, making the event more inclusive and encouraging wider participation.
The participants hailed from various locations within the organisation, including the Alloga warehouse team, Preston Service Centre warehouse team, Exeter Service Centre drivers, and Support Office teams at Chessington, showcasing the unity and collaborative spirit of Alliance Healthcare. Their combined efforts and dedication to the cause were instrumental in reaching the fundraising goal.
Sam Unsworth, Head of Communications at Alliance Healthcare and a participant in the event said: "Being part of such a significant challenge for a noble cause has been an incredible experience. The determination and teamwork displayed by everyone has been inspiring. I'm proud that so many team members have come together once again to raise much needed funding for Action Medical Research.”
Lucy Holloway, Corporate Events Fundraiser at Action Medical Research, said: "We are immensely grateful for the continued support from Alliance Healthcare UK. The funds raised will go a long way in supporting our mission to save and change children’s lives through medical research.”
The Race the Sun Jurassic Coast Challenge 2024 not only highlights the physical endurance and dedication of Alliance Healthcare and Alloga team members, but also underscores the company's commitment to creating healthier futures through fundraising for charitable causes and community support.